KJERNISTED, KD. (Invited Speaker) The Neurobiology of the Symptoms in the Treatment of Anxiety Disorders “Causes and Cures”. Canadian Psychiatric Association Annual Meeting, Vancouver, British Columbia, November 5, 2005

  
  KJERNISTED, KD. (Invited Speaker) Canadian Anxiety Treatment Guideline Initiative (Guidelines for Generalized Anxiety Disorders), Satellite Meeting, Canadian Psychiatric Association Annual Meeting, Vancouver, British Columbia, November 3, 2005

  
  KJERNISTED,  KD. (Invited Speaker) Plenary Address- Treatment Strategies for Pure and Comorbid Anxiety Disorders. Workshops- Special Topics in the Treatment of Depression.  Chinese Society of Psychiatry.  2005 Asia-Pacific Neuroscience Summit.  Beijing, China. June 17-19, 2005.

 
  KJERNISTED, KD. (Invited Speaker) Pharmacological Treatment of Bipolar Disorder.  Manitoba Pharmaceutical Association.  May 7, 2005.

  
  KJERNISTED, KD.  (Invited Speaker) Molecular Neurobiology of Anxiety Disorders.  Canadian Psychiatric Association Annual Meeting, Montreal, Quebec, October 16, 2004.

  
  KJERNISTED, KD.  (Invited Speaker) The Mind-Body Connection in PTSD: Stress Response Gone Awry, Clinical and Research Nursing Network 10th Anniversary, Winnipeg, Manitoba, September, 25, 2004.

  
  KJERNISTED, KD.  (Invited Speaker) Neurobiology of Mood Disorders.  Saskatchewan Psychiatric Annual Association, Regina, Saskatchewan, April 24, 2004.

  
  KJERNISTED, KD.  (Invited Speaker) Anxiety and the Cinema.  Alberta Psychiatric Association Annual Meeting, Banff, Alberta,  March 19, 2004.

  
  KJERNISTED, KD.  (Invited Speaker) Anxiety and the Cinema.  Ontario Psychiatric Association Annual Meeting, Toronto, Ontario,  January 31, 2004.

  
  KJERNISTED, KD.  (Invited Speaker)  Bipolar and Anxiety Disorder - A Case Presentation.  Annual Psych Update, Department of Psychiatry, University of Manitoba.  January 23, 2004.

  
  KJERNISTED, KD.  (Invited Speaker) CANMAT  Update on Anxiety Disorders - Neurobiology of PTSD & Implications for Treatment, presented at Canadian Psychiatric Association Annual Meeting, Halifax, Nova Scotia.  November 1, 2003.

  
  KJERNISTED, KD.  Development of the Worry-3 Screening Tool.  Presented University of Manitoba, Department of Psychiatry, Faculty Research Forum.  June 17, 2003.

  
  KJERNISTED, K.D. (Invited Speaker) “Treating Anxiety to Remission” Victoria Annual Anxiety Disorders Conference, April 12, 2003.

  
  KJERNISTED, K., Chartier, M., Sareen, J.  Impairment in Anxiety Disorders with Comorbid Bipolar Disorder.  Poster presented at the Anxiety Disorders Association of America 23rd National Conference, Toronto, March 2003.

 
  CHARTIER, M., Kjernisted, K.  Comparing Impairment in Pure Specific Phobia and Specific Phobia with Comorbid Disorders.  Poster presented at the Anxiety Disorders Association of America 23rd National Conference, Toronto, March 2003.

  
  VAN AMERINGEN, M., Mancini, C., Oakman, J., Walker, J., Kjernisted, K., Chokka, P, Johnston, D.  Not All Serotonergic Agents are Created Equal in Social Phobia: Nefazodone  A Placebo Controlled Trial.  Poster presented at the Anxiety Disorders Association of America 23rd National Conference, Toronto, March 2003.

  
  KJERNISTED, K.D. (Invited Speaker) “Anxiety in the Cinema” Inaugural Anxiety Disorders of Canada (ADAC) Meeting, March 30, 2003.

  
  KJERNISTED, K.D., (Invited Examiner) Senior Resident Royal College Examination Prep Course, University of Western Ontario, January 16-19, 2003.

  
  KJERNISTED, K.D. (Invited Speaker) “Interface Between Bipolar Disorder and Anxiety Disorders” University of Alberta, November 9, 2002.

  
  KJERNISTED K.D., .SILVERSTONE, P., KATZMAN, M., BAKISH, D.,
Soothing the Buzz: the Treatment of Chronic Anxiety Disorders.  Presented at the Canadian Psychiatric Association Annual Meeting, Banff, Alberta, November 2002.

  
  KJERNISTED, K.D.  (Invited Speaker) “Pharmacotherapy of OCD” Annual OCC Conference, October 5, 2002.

  
  KJERNISTED, K.D.  (Invited Speaker) “ PTSD” Saskatchewan Psychiatric Association Annual Meeting, April 2002.

  
  KJERNISTED, K.D.  (Invited Speaker)  “Treatment Refractory OCD” Quebec City, April 2002.

  
  KJERNISTED K.D., (Invited Examiner) Senior Resident Royal College Examination Prep Course, University of Western Ontario, Feb 28-March 2, 2002.

  
  KJERNISTED K.D., MEDINA, F. The Worry-3 Development and Validation of a New Measure for Generalized Anxiety Disorder. Poster presented at the Anxiety Disorders Association of America 22rd National Conference, Austin, Texas 2002.

  
  KJERNISTED,K.D., CHARTIER, M.,. The Interface Between Anxiety Disorders and Bipolar Disorder in a Community Sample. Poster presented at the Anxiety Disorders Association of America 22rd National Conference, Austin, Texas 2002.

  
  WALKER, J.R., EDIGER, J., JOYCE, B., FURER, P., VINCENT, N., & KJERNISTED, K.D.  A Survey of Preference for Pharmacological and Psychological Treatment for Anxiety Problems in and Anxiety Disorders Clinic.  Poster presented at the Anxiety Disorders Association of America 21st National Conference, Atlanta, March 2001.

  
  WALKER, J.R., KATZ, A., EDIGER, J., SEXTON, K., KJERNISTED, K.D.  Facilitating Informed Decision Making: What Would the Public Like to Know in Making Decisions About Treatment for Anxiety and Depression?  Poster presented at the Anxiety Disorders Association of America 21st National Conference, Atlanta, March 2001.

  
  KJERNISTED, K.D., CHARTIER, M., & WALKER, J.R.  Medical Conditions in Anxiety Disorders Poster presented at the Anxiety Disorders Association of America 21st National Conference, Atlanta, March 2001.

  
  KJERNISTED, K.D. (Invited Speaker) “Update on Anxiety and Depression” Manitoba Association of Asian Physicians Winter Symposium, March 3, 2001.

  
  KJERNISTED, K.D.  (Invited Speaker)  “Generalized Anxiety Disorder: Epidemiology, Diagnosis and Implications” Annual Meeting of the Ontario Psychiatric Association, Toronto, Ontario, January 19, 2001.

  
  WALKER, J.R., KATZ, A, SEXTON, K., AFIFI, T., KJERNISTED, K.D.  “A Survey of Preference for Pharmacological and Psychosocial Treatment for Anxiety Problems in a Primary Care Setting.”  Poster presented at the Association for the Advancement of Behaviour Therapy Annual Conference, New Orleans, November, 2000.

  
  KJERNISTED, K.D.  (Invited speaker)  “The Spectrum of Mood and Anxiety Disorders: Pitfalls in diagnosis and Treatment.  AMPQ (Quebec Psychiatric Association Annual Meeting).  Quebec City, May 2000.

  
  ASMUNDSON, G.J., WALKER, J.R., FURER, P.,  KJERNISTED, K.D. “Beyond Anxiety: A Preliminary Look at Acute and Chronic Pain in Individuals Seeking Treatment for Anxiety Disorders.” Paper presented at the Anxiety Disorders Association of America 20th National Conference, Washington, March 2000.

  
  CHARTIER, M., WALKER, J.R.,  KJERNISTED, K.D. “Health Care Utilization and Anxiety Disorders.” Poster presented at the Anxiety Disorders Association of America 20th National Conference, Washington, March 2000.

  
  WALKER, J.R., JOYCE, B., FURER, P., VINCENT, N., KJERNISTED, K.D.“Facilitating Informed Decision Making: A Survey of Patients Referred to a Specialty Anxiety Disorders Program.” Poster presented at the Anxiety Disorders Association of America 20th National Conference, Washington, March 2000.

 
  TORGRUD, L.J., WALKER, J.R., MURRAY, L., CHARTIER, M., KJERNISTED,
K.D.  “Social Support in Persons with Generalized Social Phobia at Pre and Post-Treatment.”  Poster presented at the Anxiety Disorders Association of America 20th National Conference, Washington, March 2000.

  
  WALKER, J.R., KJERNISTED, K.D., TORGRUD, L.J., CHARTIER, M.,
LANGAN, S.“Do Persons Participating in Trials of Pharmacological Treatments of Generalized Social Phobia Differ?” Poster presented at the Anxiety Disorders Association of America 20th National Conference, Washington, March 2000.

 
  KJERNISTED, K.D. (Invited Speaker) “Review of Norepinephrine, The NRI Class and Reboxetine in the Treatment of Depression.” Ontario Psychiatric Association Annual Meeting, Toronto, January 2000.

  
  PIDLUBNY, S.R., COX, B.J., ENNS, M.W., WALKER, J.R., KJERNISTED,
K.D.  “Diagnostic Specificity of Proposed Psychological Vulnerabilities in Patients with Major Depression versus Panic Disorder.” Paper presented at the Association for the Advancement of Behaviour Therapy Annual Conference, Toronto, November 1999.

  
  KJERNISTED, K.D. (Invited Speaker) “Diagnosis and Treatment of Social Anxiety Disorder.” Canadian Psychiatric Association Annual Meeting, Toronto, September 1999.

  
  WALKER, J.R., VINCENT, N., FURER, P., COX, B.J., ENNS, M.W., KJERNISTED, K.D. “Death anxiety in Hypochondriasis.” Poster presented at the Anxiety Disorders Association of America 19th National Conference, San Diego, March 1999.

  
  FURER, P., KJERNISTED, K.D., COX, B.J. “Diagnostic and Assessment Issues in Social Phobia.“ Paper presented at the Canadian Psychological Association Annual Convention, Edmonton, Alberta, June 1998.

  
  KJERNISTED, K.D. “Management of Treatment Refractory Social Phobia and OCD.” Annual CANMAT Education Day, Montreal, June 1998.

  
  KJERNISTED, K.D., FURER, P., WALKER, J.R., TATARYN, D., VINCENT, N. “Chronic Medical Conditions in Persons with Hypochondriasis.” Paper presented at the Anxiety Disorders Association of America Annual Conference, Boston, March 1998.

 
  FURER, P., WALKER, J.R., VINCENT, N., KJERNISTED, K.D., LESTER, M., COX, B. “Traumatic and Illness Related Childhood Events in Adults with Hypochondriasis.”Paper presented at the Anxiety Disorders Association of America Annual Conference, Boston, March 1998.

 
  WALKER, J.R., VINCENT, N., FURER, P., KJERNISTED, K.D. “Preference of Medication and Cognitive  Behavioural Treatment Among Persons with Hypochondriasis: Preliminary Findings.” Paper presented at the Anxiety Disorders Association of America Annual Conference, Boston, March 1998.

  
  TORGRUD, L., WALKER, J.R., MURRAY, L., CHARTIER, M., KJERNISTED, K.D.  “Pre and Post-Treatment Levels of Social Support in Persons with Generalized Social Phobia.” Paper presented at the Anxiety Disorders Association of America Annual Conference, Boston, March 1998.

  
  FURER, P., KJERNISTED, K.D., COX, B.J. Diagnostic and Assessment Issues in Social Phobia. Canadian Psychology, 39.88. (1998)

  
  KJERNISTED, K.D. "Sex, Drugs and Obsessive Compulsive Disorder". O.C.C. Annual Conference, Winnipeg, 1997.

  
  WALKER, J.R., KJERNISTED, K.D., TORGRUD, L., CHARTIER, M. “Do persons participating in trials of pharmacological and psychological treatments for generalized social phobia differ in personal characteristics?” Paper presented at the Anxiety Disorders Association of America Annual Conference, New Orleans, March 1997.

  
  TORGRUD, L., WALKER, J.R., MURRAY, L., CHARTIER, M., KJERNISTED, K.D. “Social Support in Persons with Generalized Social Phobia.” Paper presented at the Anxiety Disorders Association of America Annual Conference, New Orleans, March 1997.

  
  FURER, P., WALKER, J.R., TATARYN, D., KJERNISTED, K.D. “Chronic Medical Conditions in Panic Disorder”. Paper presented at the Anxiety Disorders Association of America Annual Conference, New Orleans, March 1997.

 
  KJERNISTED, K.D. “Pharmacotherapy of Obsessive Compulsive Disorder”.  Article in O.C.C. Newsletter, Fall 1996.

  
  KJERNISTED, K.D. “Pharmacologic Treatment of Obsessive Compulsive Disorder”. O.C.C. Annual Conference, Winnipeg, 1996.

  
  KJERNISTED, K.D. “Pharmacotherapy of Obsessive Compulsive Disorder”.
O.C.C. Annual Conference, Winnipeg, 1995.

  
  McINTOSH, D., VGH Department of Family Practice- September 2006

  
  McINTOSH, D., Mood Disorders Clinic Research Rounds- May 2006

  
  McINTOSH, D., VGH Department of Psychiatry Rounds- June 2006

  
  McINTOSH, D., Fraser Valley Psychiatric Association- June 2006

  
  McINTOSH, D., St. Paul’s Eating Disorders Clinic In-service- June 2006

  
  KJERNISTED, K.D. 1994 – Present: Invited speaker for approximately 300 presentations (Family Physicians and Psychiatrists) given at CME events and hospital Grand Rounds in Winnipeg, Rural Manitoba, Thunder Bay, Toronto, Kitchener, Victoria, Kelowna, Quebec City, Montreal, Saskatoon, Regina, Vancouver, Edmonton, Bermuda, Banff, Whistler, Miami, Philadelphia, San Francisco, Beijing on the following topics:
  • Treatment of Depression
  • Compliance Issues in the Treatment of Depression
  • Treatment Resistant Depression
  • Treatment of Obsessive Compulsive Disorder
  • Treatment of Panic Disorder
  • Treatment of Social Phobia
  • Treatment of Generalized Anxiety Disorder
  • Treatment of PTSD
  • Treatment of Sexual Dysfunction from Antidepressants
  • Management of Side Effects of the Newer Antidepressants
  • Comorbid Anxiety and Depression
  • Fibromyalgia
  • Treatment Refractory Panic Disorder, SAD, OCD, PTSD GAD
  • Obesity and Psychiatry
  • Interface Between Anxiety Disorders and Bipolar Disorder
  • Molecular Neurobiology of Mood and Anxiety Disorders
  • Anxiety in the Cinema
  • Practitioners Guide to Data Analysis (CANMAT)
  • Treatment of Residual Symptoms of Mood and Anxiety D/Os
  • Neurobiology of Mood and Anxiety Disorders- Monoamines
  • Psychoneuroimmunology
 

Dr. Kevin Kjernisted: Grand Rounds Presentations
  June 3, 2005- Grand Rounds Presentation, Department of Psychiatry, University of Calgary, “Treatment of Residual Symptoms of Mood and Anxiety Disorders”

  
  Feb 2, 2005- Grand Rounds Presentation, Department of Psychiatry, University of Manitoba, “Molecular Neurobiology of Mood and Anxiety Disorders”

 
  April 22, 2003- Grand Rounds Presentation, Department of Psychiatry, University of Manitoba, “Anxiety and the Cinema”.

 
  April 11, 2003- Grand Rounds Presentation, Department of Psychiatry, University of British Columbia (Vancouver General Hosp). “Treating Anxiety Disorders to Remission”.

 
  March 27, 2003- Grand Rounds Presentation, Department of Psychiatry, University of Toronto (CAMH). “Interface Between Anxiety Disorders and Bipolar Disorder”.

  
  Sept 24, 2002- Grand Rounds Presentation, Department of Psychiatry, University of Manitoba. “Neurobiology of PTSD and Implications for Treatment”.

  
  April 19, 2002- Grand Rounds Presentation, Department of Psychiatry, University of Calgary.  “Interface Between Anxiety Disorders and Bipolar Disorder”.

  
  April 12,  2002- Grand Rounds Presentation, Department of Psychiatry, McGill University.  “Interface Between Anxiety Disorders and Bipolar Disorder”.

  
  Oct 16, 2000- Grand Rounds Presentation, Department of Psychiatry, University of Regina.  “Generalized Anxiety Disorder”.

  
  Sept 22, 2000- Grand Rounds Presentation, Department of Psychiatry, University of Saskatchewan, Saskatoon.  “Update on OCD”

  
  June 6, 2000- Grand Rounds Presentation, Department of Psychiatry, University of Manitoba, “Generalized Anxiety Disorder: An Old Disorder, So What is New?”.

  
  June 29, 1999- Grand Rounds Presentation, Department of Psychiatry, University of Victoria, “Diagnoses and Treatment of Social Phobia”.

  
  March 9, 1999- Grand Rounds Presentation, Department of Psychiatry, University of Manitoba, “Management of Side Effects of the Newer Antidepressants”.

  
  Feb 3, 1998- Grand Rounds Presentation, Department of Psychiatry, University of Manitoba, “Fibromyalgia - Biopsychosocial Aspects”.

  
  June 3, 1997- Grand Rounds Presentation Department of Psychiatry, University of Manitoba, “Current Issues in the Treatment of Social Phobia”.  

« Back to Research
© Copeman Neuroscience Centre 2007 Privacy Policy | Site Map | Website Design